A detailed history of Planning Capital Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Planning Capital Management Corp holds 231 shares of ABBV stock, worth $41,580. This represents 0.03% of its overall portfolio holdings.

Number of Shares
231
Previous 767 69.88%
Holding current value
$41,580
Previous $132 Million 65.28%
% of portfolio
0.03%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$163.84 - $199.33 $87,818 - $106,840
-536 Reduced 69.88%
231 $45.7 Million
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $3,250 - $3,795
-21 Reduced 2.66%
767 $132 Million
Q1 2024

Apr 26, 2024

SELL
$159.82 - $182.1 $18,379 - $20,941
-115 Reduced 12.74%
788 $143 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $124,252 - $139,937
903 New
903 $140 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Planning Capital Management Corp Portfolio

Follow Planning Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Planning Capital Management Corp with notifications on news.